CN111875545A - Directional synthesis method and application of 6-substituted benzimidazole derivative - Google Patents

Directional synthesis method and application of 6-substituted benzimidazole derivative Download PDF

Info

Publication number
CN111875545A
CN111875545A CN202010689403.7A CN202010689403A CN111875545A CN 111875545 A CN111875545 A CN 111875545A CN 202010689403 A CN202010689403 A CN 202010689403A CN 111875545 A CN111875545 A CN 111875545A
Authority
CN
China
Prior art keywords
compound
substituted
synthesis
reaction
aromatic aldehyde
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010689403.7A
Other languages
Chinese (zh)
Inventor
司伟杰
高静
杨文超
吴汉夔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anyang Normal University
Original Assignee
Anyang Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anyang Normal University filed Critical Anyang Normal University
Priority to CN202010689403.7A priority Critical patent/CN111875545A/en
Publication of CN111875545A publication Critical patent/CN111875545A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention relates to a directional synthesis method and application of 6-substituted benzimidazole derivatives, wherein the structure of the derivatives is shown as 3 or 3' in a general formula (I),
Figure DDA0002588749840000011
the synthesis method provided by the invention has the advantages of easily controlled reaction conditions and single product, and can synthesize a large amount of new compounds with high yield. The compound of formula (I) of the invention has a plurality of reactive groups such as-OH, NH on the 2-position aromatic ring2(NO2Reduced), COOH (COOEt hydrolyzed), have utility as pharmaceutical intermediates, can be further reacted, introduce new active groups, and have broader utility in synthesis and drug development.

Description

Directional synthesis method and application of 6-substituted benzimidazole derivative
Technical Field
The invention relates to the field of drug synthesis, in particular to a simple and directional synthesis method and application of a 6-substituted benzimidazole derivative.
Background
The benzimidazole compound has various purposes and biological activity, such as being applied to industrial corrosion resistance, high-temperature resistant materials in aerospace, novel curing agents, catalysts, surface treatment agents of certain metals and the like, also has various medical activities of antibiosis, parasite resistance, antivirus, anticancer, antiphlogosis, analgesia and the like, and also has agricultural bactericidal and insecticidal activities, so the compound has important significance in the fields of functional materials, pesticides and medicines.
The benzimidazole compound promotes the development of the synthesis method due to various biological activities and wide application. The synthesis method of the compounds is more, wherein the condensation reaction of o-phenylenediamine and carboxylic acid and derivatives thereof is a classical method for synthesizing the benzimidazole compounds. However, this method is carried out under strong acid and high temperature conditions. Through continuous development, some reports realize the innovation of a reaction system based on the existing reaction raw materials, and some reports realize the condensation of new reaction raw materials by using a novel catalytic technology. For example, Wilson et al synthesized benzimidazole compounds under palladium-catalyzed conditions using o-phenylenediamine, aryl iodide, and carbon monoxide as starting materials (J.org.chem., 1993, 58(58): 7016-7021). However, this reaction needs to be carried out not only at high temperature (140 ℃) but also palladium as a catalyst, which limits the large-scale application.
The Nejati group uses SDS (sodium hexadecylsulfonate) as a catalyst to realize intermolecular cyclization of o-phenylenediamine compounds and aldehyde in an aqueous medium (Green. chem., 2010, 41(48): 1237-1241). The use of water as a solvent is an improvement over the conventional process, but does not improve the range of use of the conventional process.
The Vahdat group achieved condensation reactions of ethylenediamine derivatives with orthoformates and their derivatives using hexafluoroisopropanol as solvent at room temperature (J.Fluor.chem., 2010, 131(12): 1377-1381). The introduction of the fluorine-containing solvent simplifies the reaction system, promotes the reaction and enables the reaction conditions to be milder. However, the use of a fluorine-containing compound as a solvent greatly increases the cost.
Bao et al developed a new method for non-metal catalyzed synthesis of benzimidazole series compounds under solvent-free conditions (org. Lett., 2014, 16(3): 764-) -767). The target product is synthesized by taking p-toluenesulfonic acid as a catalyst and o-phenylenediamine and a 1, 3-dicarbonyl compound as raw materials under mild reaction conditions. The reaction has certain application advantages in terms of reaction conditions and raw materials. However, 1, 3-dicarbonyl compounds are starting materials that undergo C-C bond cleavage, which limits regioselectivity.
The study of Saha et al uses o-nitrobenzaldehyde and 3, 4-diaminotoluene as raw materials and sodium bisulfate as a catalyst to obtain a 5-position and 6-position substituted mixture (Synthetic Communications,2007,37(19): 3455-3470). The synthesis of quinazolinone derivatives from benzimidazole intermediates reported by Ji et al was also a mixture (j. org. chem.2013,78, 4312-4318).
In summary, the benzimidazole compound has various synthetic methods and raw materials, and various synthetic methods and routes have characteristics. However, few methods have been reported for synthesizing benzimidazole compounds with a single substituent group, or there is a simple report without direct evidence to prove that the compounds are single products.
Disclosure of Invention
The invention takes various aromatic aldehydes, sodium bisulfite and (4-position single substitution) o-phenylenediamine as raw materials, and the 6-position substituted benzimidazole compound is formed through cyclization. The compound can continue to react with other intermediates, and can be used for drug synthesis at specific positions and structure-activity relationship research.
One of the objects of the present invention is to provide a 6-substituted benzimidazole compound. The structure of the compound is shown as 3 or 3' in the general formula (I),
Figure BDA0002588749820000021
in formula (I) 3: x1Selected from N, CR1;X2Selected from N, CR2;X3Selected from N, CR3;X4Selected from N, CR4;R1、R2、R3、R4Selected from H, halogen, C1-3Alkyl radical, C1-3Alkoxy radicalRadical, C substituted by 1 or more halogens1-3Alkyl, C substituted by 1 or more halogens1-3Alkoxy group, NO2OH, COOEt; r is selected from halogen and NO2、C1-3Alkyl radical, C1-3Alkoxy, C substituted by 1 or more halogens1-3Alkyl, C substituted by 1 or more halogens1-3An alkoxy group;
preferably: r1、R2、R3、R4Selected from H, F, Cl, Br, I, Me, OMe, CF3、OCF3、NO2OH, COOEt; r is selected from F, Cl, Br, I, NO2、Me、OMe、CF3、OCF3
Further preferably: r1、R2、R3、R4Selected from H, F, Cl, Br, Me, OMe, CF3、OCF3、NO2OH, COOEt, R is selected from F, Cl, Br, I, NO2、Me、OMe、CF3、OCF3
Even more preferably, R1、R2、R3、R4Selected from NO2、OH、COOEt;
Het in 3' of the formula (I) is substituted or unsubstituted thiazole, oxazole, isoxazole, imidazole, pyrazole, furan, thiophene; preferably thiazole, oxazole, imidazole, pyrazole, furan, thiophene; more preferably thiazole, oxazole, pyrazole, furan, thiophene.
Another object of the present invention is to provide a method for synthesizing a compound of formula (I), comprising the steps of: taking aromatic aldehyde or substituted aromatic aldehyde and 4-substituted o-phenylenediamine as raw materials to synthesize compounds 3 and 3 ', wherein the reaction equations are expressed by the following general formulas (A) and (A'):
Figure BDA0002588749820000022
preferably, the method comprises the following steps of taking aromatic aldehyde or substituted aromatic aldehyde, sodium bisulfite and 4-position monosubstituted o-phenylenediamine as raw materials, and performing cyclization to form 6-position substituted benzimidazole compound 3 or 3 ', wherein the 6-position substituted benzimidazole compound 3 or 3' reacts with a compound with an active group to synthesize the derivative substituted at a specific position.
Further preferably, the method comprises the steps of,
s1: dissolving aromatic aldehyde or substituted aromatic aldehyde in ethanol, dissolving 1.05-1.1 equivalent of sodium bisulfite in water, mixing the two under the condition of vigorous stirring, and continuously stirring for 5-15min to obtain corresponding sodium salt;
s2, drying the sodium salt of S1, adding the dried sodium salt and an equivalent amount of 4-R substituted o-phenylenediamine compound into DMF, heating to a reflux temperature, and stirring for reacting for 2-4 hours;
s3: pouring the reaction liquid of S2 into a beaker filled with crushed ice, stirring uniformly, standing to separate out a solid, and carrying out suction filtration, drying and recrystallization on the solid to obtain the 6-substituted benzimidazole compound 3 or 3';
s4: the 6-substituted benzimidazole compound 3 or 3' of the S3 product reacts with a compound with an active group to synthesize the derivative substituted at a specific position, and the yield is 55-75%.
More preferably, the reaction of the 6-substituted benzimidazole compound 3 or 3' with the compound with the active group comprises one or more of reduction reaction, substitution reaction and condensation reaction.
Still more preferably, the compound having a reactive group includes a compound having a carbonyl group, a compound having an amino group, or a compound having a hydroxyl group.
The invention also provides a compound synthesized by the method of any one of the above.
Further preferably, the compounds and derivatives thereof have the following structure:
Figure BDA0002588749820000031
the invention also provides the application of the compound, namely the application of the compound in synthesis; preferably, the compound is used as an intermediate in the field of drug synthesis; further preferably, the compound is used as an intermediate for synthesizing pesticides and medicines; further preferably, the compound is used as an intermediate for the directional (6-position substitution) synthesis of pesticides and medicines.
The invention also provides an application of the synthesis method in the field of drug synthesis; preferably, the synthesis method is applied to the synthesis of pesticides and medicines; further preferably, the synthesis method is applied to the directed synthesis of 6-substituted pesticides and medicines.
Has the advantages that:
1. the compounds of formula (I) of the invention have novel molecular structures, and are 6-substituted benzimidazole compounds.
2. The synthesis method provided by the invention has the advantages of simple operation, easily obtained raw materials, easily controlled reaction conditions and single product, and synthesizes a large amount of new compounds with higher yield. The specific method comprises the following steps: various aromatic aldehydes, sodium bisulfite and (4-site single substituted) o-phenylenediamine are taken as raw materials to form the 6-site substituted benzimidazole compound through cyclization. The compound can continue to react with other intermediates, and the synthesis of the drug intermediate at a specific position and the research on the structure-activity relationship can be carried out. The synthesis method has the advantages that: 1) firstly, various aromatic aldehydes react with sodium bisulfite to generate relatively stable sodium salt, and the stability of the sodium salt is greatly improved compared with the aromatic aldehydes; 2) various metal or nonmetal catalysts are not needed, so that the cost is low; 3) the post-reaction treatment is simple; 4) the synthesized compound is a single product; 5) the products of specific substitution sites have important practical significance in drug research, especially structure-activity relationship research.
3. The compound of formula (I) of the invention has a plurality of reactive groups such as-OH, NH on the 2-position aromatic ring2(NO2Reduced), COOH (COOEt hydrolyzed), have utility as pharmaceutical intermediates, can be further reacted, introduce new active groups, and have broader utility in synthesis and drug development.
Drawings
FIG. 1 is an X-ray single crystal diffraction ellipsoid plot of compound I35-Chloro-1, 3-dimethyl-N- (2- (6-methyl-1H-benzimidazol-2-yl) phenyl) -1H-pyrazole-4-carboxamide.
Detailed Description
The essential features of the invention can be seen from the following examples, which should not be construed as limiting the invention in any way.
Synthetic examples
Example 1: synthesis of substituted- (6-R-1H-benzimidazol-2-yl) anilines (4A) (R has the meaning as defined in claims 1 to 3 The meanings of
Compound (A) to (B)4A) Synthesized by the following method:
Figure BDA0002588749820000041
nitrobenzaldehyde (37.8g,250mmol) was dissolved in 50mL ethanol, sodium bisulfite (27.3g,262mmol) was dissolved in 50mL water, and the two were mixed under vigorous stirring for an additional 5-15min to give the corresponding sodium salt. After the sodium salt is dried, the sodium salt and a 4-R substituted o-phenylenediamine compound (250mmol) are added into 80mLDMF together, the temperature is raised to the reflux temperature, and the stirring reaction is carried out for 2-4 h. Pouring the reaction liquid into a beaker filled with crushed ice, stirring uniformly, standing to separate out solid, carrying out suction filtration, drying and recrystallization on the solid to obtain 3A, and reducing by stannous chloride or iron powder to obtain 4A, wherein the yield is 55-75% in three steps.
3-(6-chloro-1H-benzo[d]imidazol-2-yl)aniline
Figure BDA0002588749820000042
Yellow powder, yield 75%,1H NMR(400MHz,DMSO-d6):12.97(s,1H),7.65–7.52(m,2H),7.44–7.39(m,1H),7.27(d,J=7.8Hz,1H),7.24–7.15(m,2H),6.70(dd,J=7.9,1.3Hz,1H),5.39(s,2H).
4-(6-chloro-1H-benzo[d]imidazol-2-yl)aniline
Figure BDA0002588749820000043
yellow powder, yield 78%,1H NMR(400MHz,DMSO-d6):12.64(s,1H),7.84(d,J=8.6Hz,2H),7.55–7.40(m,2H),7.13(dd,J=8.5,2.0Hz,1H),6.67(d,J=8.6Hz,2H),5.68(s,2H).
3-(6-methyl-1H-benzo[d]imidazol-2-yl)aniline
Figure BDA0002588749820000051
1H NMR(400MHz,DMSO-d6):12.56(s,1H),7.51–7.39(m,2H),7.34(s,1H),7.24(t,J=10.4Hz,1H),7.16(t,J=7.8Hz,1H),7.00(dd,J=8.2,0.8Hz,1H),6.67(dd,J=7.9,1.4Hz,1H),5.32(s,2H),2.42(s,3H).
4-(6-methyl-1H-benzo[d]imidazol-2-yl)aniline
Figure BDA0002588749820000052
1H NMR(400MHz,DMSO-d6):12.33(s,1H),7.82(d,J=8.6Hz,2H),7.36(d,J=8.0Hz,1H),7.27(s,1H),6.93(dd,J=8.1,1.0Hz,1H),6.67(t,J=11.9Hz,2H),5.59(s,2H),2.40(s,3H).
example 2: synthesis of substituted- (6-R-1H-benzimidazol-2-yl) phenol (3B)
Compound (A) to (B)3B) Synthesized by the following method:
Figure BDA0002588749820000053
hydroxybenzaldehyde (30.5g,250mmol) was dissolved in 50mL ethanol, sodium bisulfite (27.3g,262mmol) was dissolved in 50mL water, and the two were mixed under vigorous stirring for further 5-15min to give the corresponding sodium salt. After the sodium salt is dried, the sodium salt and a 4-R substituted o-phenylenediamine compound (250mmol) are added into 80mLDMF together, the temperature is raised to the reflux temperature, and the stirring reaction is carried out for 2-4 h. Pouring the reaction solution into a beaker filled with crushed ice, stirring uniformly, standing to separate out solid, carrying out suction filtration, drying and recrystallization on the solid to obtain 3A, wherein the yield of the two steps is 65-88%.
Example 3: synthesis of substituted- (6-R-1H-benzimidazol-2-yl) benzoic acid (4C) (R has the meaning given in claimRequirements 1 to 3 The meanings)
Compound (4C) was synthesized by the following method:
Figure BDA0002588749820000054
ethyl formylbenzoate (45.5g,250mmol) was dissolved in 50mL ethanol, sodium bisulfite (27.3g,262mmol) was dissolved in 50mL water, and the two were mixed under vigorous stirring for additional 5-15min to give the corresponding sodium salt. After the sodium salt is dried, the sodium salt and a 4-R substituted o-phenylenediamine compound (250mmol) are added into 80mLDMF together, the temperature is raised to the reflux temperature, and the stirring reaction is carried out for 2-4 h. Pouring the reaction solution into a beaker filled with crushed ice, stirring uniformly, standing to separate out solid, carrying out suction filtration, drying and recrystallization on the solid to obtain 3C, and carrying out alkaline hydrolysis and acidification to obtain 4C, wherein the yield is 70-85% in the three steps.
The method of the above examples 1-3 is adopted to synthesize the 6-substituted benzimidazole derivative of the formula (I), and the synthesis method is simple and convenient, has a single product and is superior to other synthesis methods. The benzimidazole compound 3 synthesized by the method can be used as an intermediate, and has important significance in the aspects of medicine synthesis and structure-activity relationship research.
Figure BDA0002588749820000061
In order to highlight the advantages and positioning effects of the synthesis method, the method can synthesize the target compound with a single configuration by taking the spectrogram data of the target compound I1-I3 as an example:
5-chloro-N-(2-(6-chloro-1H-benzo[d]imidazol-2-yl)phenyl)-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide(I1)
Figure BDA0002588749820000062
White solid,yield 41.5%,mp 225-227℃;IR(KBr)(νmax/cm–1):3407,3226,1649,1619,1539,1485,1450,1399,1325,1191,1155,1057,1033,751.
1H NMR(400MHz,DMSO-d6):13.62(s,1H),13.44(s,1H),8.78(d,J=7.8Hz,1H),8.19(dd,J=7.9,1.0Hz,1H),7.71(s,1H),7.65(d,J=8.5Hz,1H),7.62–7.55(m,1H),7.37(dd,J=11.2,4.1Hz,1H),7.31(dd,J=8.5,1.3Hz,1H),4.06(s,3H).
13C NMR(101MHz,DMSO-d6):157.9,152.1,139.2(q,J=38.3Hz),138.1,131.5,129.1,127.9,124.2,122.1,121.0,119.5,116.0,115.0,38.1.
19F NMR(376MHz,DMSO-d6):–60.38.
HRMS(ESI)Calcd for C19H13Cl2F3N5O[M+H]+:454.04438,found:454.04425.
2-chloro-N-(2-(6-methyl-1H-benzo[d]imidazol-2-yl)phenyl)nicotinamide(I2)
Figure BDA0002588749820000063
White solid,yield 70.3%,mp 150-152℃;IR(KBr)(νmax/cm–1):3249,2919,1699,1635,1613,1600,1549,1484,1431,1405,1388,1314,1269,1148,1064,799,753.
1H NMR(400MHz,DMSO-d6):13.90(s,1H),13.14(d,J=17.8Hz,1H),8.82(d,J=8.1Hz,1H),8.66(d,J=3.0Hz,1H),8.33(dd,J=7.6,1.7Hz,1H),8.18(d,J=7.9Hz,1H),7.71(dd,J=12.1,6.1Hz,1H),7.58(t,J=7.8Hz,1H),7.50–7.34(m,2H),7.32–7.18(m,1H),7.08(dd,J=30.7,8.1Hz,1H),2.42(d,J=19.7Hz,3H).
13C NMR(101MHz,DMSO-d6):163.8,151.7,147.2,138.9,138.1,133.0,131.1,127.6,124.2,123.9,120.5,118.3,116.5,111.6,21.7(d,J=21.2Hz).
1H NMR(400MHz,CDCl3):13.60(s,1H),10.22(s,1H),8.83(d,J=8.1Hz,1H),8.56(dd,J=4.8,1.9Hz,1H),8.15(dd,J=7.6,1.9Hz,1H),7.73(d,J=7.9Hz,1H),7.46–7.36(m,3H),7.30(s,1H),7.16(t,J=7.6Hz,1H),7.10(d,J=8.2Hz,1H),2.46(s,3H).
HRMS(ESI)Calcd for C20H16ClN4O[M+H]+:363.10072,found:363.10059.
5-Chloro-1,3-dimethyl-N-(2-(6-methyl-1H-benzimidazol-2-yl)phenyl)-1H-pyrazole-4-carboxamide(I3)
Figure BDA0002588749820000071
White solid,yield 53.0%,mp 220-222℃;IR(KBr)(νmax/cm–1):3280,2860,1643,1613,1590,1551,1524,1485,1429,1363,1310,1265,962,902,762,632,599.
1H NMR(400MHz,DMSO-d6):13.32(s,1H),13.07(d,J=16.9Hz,1H),8.81–8.71(m,1H),8.13(d,J=7.9Hz,1H),7.49(dd,J=16.1,8.6Hz,2H),7.40(d,J=19.1Hz,1H),7.30(t,J=7.6Hz,1H),7.10(dd,J=19.3,8.1Hz,1H),3.86(s,3H),2.46(t,J=7.2Hz,6H).
13C NMR(101MHz,DMSO-d6):160.6,150.9,150.5,148.1(d,J=10.7Hz),142.8,140.62,138.5,134.3,133.3,132.0,131.8,130.7,127.6(d,J=12.8Hz),125.3,124.3,123.5,121.2,118.4(d,J=7.4Hz),116.4,113.6,111.5(d,J=14.2Hz),36.6,21.7(d,J=17.4Hz),14.2.
1H NMR(400MHz,CDCl3):12.87(s,1H),10.55(s,1H),8.59(d,J=8.3Hz,1H),7.62(d,J=7.1Hz,1H),7.47(d,J=7.2Hz,1H),7.36(s,1H),7.12(dd,J=16.4,7.9Hz,2H),6.93(t,J=7.4Hz,1H),3.88(s,3H),2.64(s,3H),2.48(s,3H).
13C NMR(101MHz,CDCl3):161.99,150.26,149.15,137.71,130.09,128.98,126.67,124.61,123.41,122.17,117.21,113.68,36.31,21.75,14.39.HRMS(ESI)Calcdfor C20H19ClN5O[M+H]+:380.12726,found:380.12711.
the X-ray single crystal diffraction ellipsoid pattern of the compound I3 is shown in the attached figure 1 of the specification, and the attached figure 1 directly proves that the compound is actually substituted at the 6-position.
1,3-dimethyl-N-(4-(6-methyl-1H-benzo[d]imidazol-2-yl)phenyl)-1H-pyrazole-5-carboxamide(I4)
Figure BDA0002588749820000081
White powder, yield 70.5%,1H NMR(400MHz,CDCl3):8.21(s,1H),7.93(d,J=8.4Hz,2H),7.59(d,J=8.5Hz,2H),7.49(d,J=8.2Hz,1H),7.33(d,J=15.9Hz,1H),7.07(d,J=8.2Hz,1H),6.50(s,1H),4.09(s,3H),2.44(s,3H),2.25(s,3H).
5-chloro-1,3-dimethyl-N-(4-(6-methyl-1H-benzo[d]imidazol-2-yl)phenyl)-1H-pyrazole-4-carboxamide(I5)
Figure BDA0002588749820000082
off-white powder, yield 72.3%,1H NMR(400MHz,CDCl3):8.06–7.92(m,3H),7.72(d,J=8.5Hz,2H),7.51(s,1H),7.38(s,1H),7.08(d,J=8.3Hz,1H),3.86(s,3H),2.53(s,3H),2.47(s,3H).
3-isobutyl-1-methyl-N-(4-(6-methyl-1H-benzo[d]imidazol-2-yl)phenyl)-1H-pyrazole-5-carboxamide(I6)
Figure BDA0002588749820000083
white powder, yield 75.6%,1H NMR(400MHz,CDCl3):8.08(s,1H),7.96(d,J=8.3Hz,2H),7.62(d,J=8.3Hz,2H),7.47(t,J=11.7Hz,1H),7.06(d,J=8.2Hz,1H),6.51(s,1H),4.13(s,3H),2.49(d,J=6.9Hz,3H),2.44(s,3H),1.91(tt,J=13.4,6.8Hz,1H),0.94(d,J=6.6Hz,6H).
2-chloro-N-(4-(6-methyl-1H-benzo[d]imidazol-2-yl)phenyl)nicotinamide(I7)
Figure BDA0002588749820000084
white powder, yield 85.8%,1H NMR(400MHz,DMSO-d6):10.65(s,1H),9.15(d,J=1.8Hz,1H),8.79(d,J=4.7Hz,1H),8.33(d,J=7.9Hz,1H),8.16(d,J=8.6Hz,2H),7.96(d,J=8.6Hz,2H),7.58(dt,J=18.3,9.1Hz,1H),7.47(d,J=8.1Hz,1H),7.37(s,1H),7.02(d,J=8.2Hz,1H),2.44(s,3H).
N-(4-(6-chloro-1H-benzo[d]imidazol-2-yl)phenyl)-1,3-dimethyl-1H-pyrazole-5-carboxamide(I8)
Figure BDA0002588749820000085
white powder, yield 68.5%,1H NMR(400MHz,DMSO-d6):13.06(s,1H),10.35(s,1H),8.16(d,J=8.6Hz,2H),7.93(d,J=8.6Hz,2H),7.59(s,2H),7.19(t,J=12.7Hz,1H),6.89(s,1H),4.03(s,3H),2.22(s,3H).
5-chloro-N-(4-(6-chloro-1H-benzo[d]imidazol-2-yl)phenyl)-1,3-dimethyl-1H-pyrazole-4-carboxamide(I9)
Figure BDA0002588749820000091
white powder, yield 70.4%,1H NMR(400MHz,DMSO-d6):13.14(s,1H),10.14(s,1H),7.72(dd,J=243.4,137.9Hz,7H),3.82(s,3H),2.34(s,3H).
N-(4-(6-chloro-1H-benzo[d]imidazol-2-yl)phenyl)-3-isobutyl-1-methyl-1H-pyrazole-5-carboxamide(I10)
Figure BDA0002588749820000092
white powder, yield 72.8%,1H NMR(400MHz,CDCl3):8.04(d,J=8.5Hz,2H),7.82–7.70(m,3H),7.67–7.51(m,2H),7.23(s,1H),6.47(s,1H),4.17(s,3H),2.52(d,J=7.1Hz,2H),1.93(td,J=13.6,6.8Hz,1H),0.96(t,J=6.9Hz,6H).
2-chloro-N-(4-(6-chloro-1H-benzo[d]imidazol-2-yl)phenyl)nicotinamide(I11)
Figure BDA0002588749820000093
white powder, yield 83.2%,1H NMR(400MHz,DMSO-d6):13.03(s,1H),10.68(s,1H),9.15(d,J=1.8Hz,1H),8.79(d,J=4.6Hz,1H),8.32(t,J=7.3Hz,1H),8.18(d,J=8.6Hz,2H),7.99(d,J=8.6Hz,2H),7.70–7.51(m,3H),7.21(dd,J=8.5,1.6Hz,1H).
those of ordinary skill in the art will understand that: the invention is not to be considered as limited to the specific embodiments thereof, but is to be understood as being modified in all respects, all changes and equivalents that come within the spirit and scope of the invention.

Claims (10)

1. A compound, the structure of which is shown as 3 or 3' in the general formula (I),
Figure FDA0002588749810000011
in formula (I) 3: x1Selected from N, CR1;X2Selected from N, CR2;X3Selected from N, CR3;X4Selected from N, CR4;R1、R2、R3、R4Selected from H, halogen, C1-3Alkyl radical, C1-3Alkoxy, C substituted by 1 or more halogens1-3Alkyl, C substituted by 1 or more halogens1-3Alkoxy group, NO2OH, COOEt; r is selected from halogen and NO2、C1-3Alkyl radical, C1-3Alkoxy, C substituted by 1 or more halogens1-3Alkyl, C substituted by 1 or more halogens1-3An alkoxy group;
preferably: r1、R2、R3、R4Selected from H, F, Cl, Br, I, Me, OMe, CF3、OCF3、NO2OH, COOEt; r is selected from F, Cl, Br, I, NO2、Me、OMe、CF3、OCF3
Further preferably: r1、R2、R3、R4Selected from H, F, Cl, Br, Me, OMe, CF3、OCF3、NO2OH, COOEt, R is selected from F, Cl, Br, I, NO2、Me、OMe、CF3、OCF3
Even more preferably, R1、R2、R3、R4Selected from NO2、OH、COOEt;
Het in 3' of the formula (I) is substituted or unsubstituted thiazole, oxazole, isoxazole, imidazole, pyrazole, furan, thiophene; preferably thiazole, oxazole, imidazole, pyrazole, furan, thiophene; more preferably thiazole, oxazole, pyrazole, furan, thiophene.
2. A process for the synthesis of a compound of formula (I) as claimed in claim 1, comprising the steps of: taking aromatic aldehyde or substituted aromatic aldehyde and 4-substituted o-phenylenediamine as raw materials to synthesize compounds 3 and 3 ', wherein the reaction equations are expressed by the following general formulas (A) and (A'):
Figure FDA0002588749810000012
3. the method according to claim 2, which comprises the step of synthesizing the derivative substituted at the specific position by using aromatic aldehyde or substituted aromatic aldehyde, sodium bisulfite and 4-position mono-substituted o-phenylenediamine as raw materials and performing cyclization to form 6-position substituted benzimidazole compound 3 or 3 ', wherein the 6-position substituted benzimidazole compound 3 or 3' reacts with a compound with an active group.
4. The method of claim 3, comprising the steps of,
s1: dissolving aromatic aldehyde or substituted aromatic aldehyde in ethanol, dissolving 1.05-1.1 equivalent of sodium bisulfite in water, mixing the two under the condition of vigorous stirring, and continuously stirring for 5-15min to obtain corresponding sodium salt;
s2, drying the sodium salt of S1, adding the dried sodium salt and an equivalent amount of 4-R substituted o-phenylenediamine compound into DMF, heating to a reflux temperature, and stirring for reacting for 2-4 hours;
s3: pouring the reaction liquid of S2 into a beaker filled with crushed ice, stirring uniformly, standing to separate out a solid, and carrying out suction filtration, drying and recrystallization on the solid to obtain the 6-substituted benzimidazole compound 3 or 3';
s4: the 6-substituted benzimidazole compound 3 or 3' of the S3 product reacts with a compound with an active group to synthesize the derivative substituted at a specific position, and the yield is 55-75%.
5. The method according to claim 3 or 4, wherein the reaction of the 6-substituted benzimidazole compound 3 or 3' with the compound with the active group comprises one or more of reduction reaction, substitution reaction and condensation reaction.
6. The method according to claim 3 or 4, wherein the compound having a reactive group comprises a compound having a carbonyl group, a compound having an amino group, or a compound having a hydroxyl group.
7. A compound synthesized according to the method of any one of claims 2-6.
8. The compound of claim 7, having the structure:
Figure FDA0002588749810000021
9. use of a compound according to claim 1 or 7 for synthesis; preferably, the compound is used as an intermediate in the field of drug synthesis; further preferably, the compound is used as an intermediate for synthesizing pesticides and medicines; further preferably, the compound is used as an intermediate for the directional (6-position substitution) synthesis of pesticides and medicines.
10. Use of the method according to any one of claims 2 to 6, wherein the method of synthesis is used in the field of pharmaceutical synthesis; preferably, the synthesis method is applied to the synthesis of pesticides and medicines; further preferably, the synthesis method is applied to the directed synthesis of 6-substituted pesticides and medicines.
CN202010689403.7A 2020-07-17 2020-07-17 Directional synthesis method and application of 6-substituted benzimidazole derivative Pending CN111875545A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010689403.7A CN111875545A (en) 2020-07-17 2020-07-17 Directional synthesis method and application of 6-substituted benzimidazole derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010689403.7A CN111875545A (en) 2020-07-17 2020-07-17 Directional synthesis method and application of 6-substituted benzimidazole derivative

Publications (1)

Publication Number Publication Date
CN111875545A true CN111875545A (en) 2020-11-03

Family

ID=73155533

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010689403.7A Pending CN111875545A (en) 2020-07-17 2020-07-17 Directional synthesis method and application of 6-substituted benzimidazole derivative

Country Status (1)

Country Link
CN (1) CN111875545A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113666875A (en) * 2021-09-16 2021-11-19 湖北瑞凯兴科技股份有限公司 Method for preparing 2-phenylbenzimidazole
WO2024112287A1 (en) * 2023-08-29 2024-05-30 Banoglu Erden Benzimidazole compounds and pharmaceutical compositions and uses thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102942562A (en) * 2012-12-05 2013-02-27 天津科技大学 Benzimidazole derivative, and preparation method and application thereof
CN103524422A (en) * 2013-10-11 2014-01-22 中国农业科学院植物保护研究所 Benzimidazole derivative, and preparation method and purpose thereof
CN104529906A (en) * 2014-12-24 2015-04-22 天津药物研究院药业有限责任公司 Method for improving water solubility of hydroxybenzimidazolyl compound
US9387198B1 (en) * 2015-02-27 2016-07-12 Humera Jahan Inhibitors of advanced glycation end-products (ages)formation
WO2018233633A1 (en) * 2017-06-20 2018-12-27 南京明德新药研发股份有限公司 Ssao inhibitor
CN110746407A (en) * 2018-07-23 2020-02-04 南京农业大学 Amide derivative containing benzimidazole group, preparation method and application thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102942562A (en) * 2012-12-05 2013-02-27 天津科技大学 Benzimidazole derivative, and preparation method and application thereof
CN103524422A (en) * 2013-10-11 2014-01-22 中国农业科学院植物保护研究所 Benzimidazole derivative, and preparation method and purpose thereof
CN104529906A (en) * 2014-12-24 2015-04-22 天津药物研究院药业有限责任公司 Method for improving water solubility of hydroxybenzimidazolyl compound
US9387198B1 (en) * 2015-02-27 2016-07-12 Humera Jahan Inhibitors of advanced glycation end-products (ages)formation
WO2018233633A1 (en) * 2017-06-20 2018-12-27 南京明德新药研发股份有限公司 Ssao inhibitor
CN110746407A (en) * 2018-07-23 2020-02-04 南京农业大学 Amide derivative containing benzimidazole group, preparation method and application thereof

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ANTONIO LAGHEZZA ET AL.: "Virtual screening identification and chemical optimization of substituted 2-arylbenzimidazoles as new non-zinc-binding MMP-2 inhibitors", 《BIOORGANIC & MEDICINAL CHEMISTRY》 *
P.B.SHERLY MOLE ET AL.: "Amphiphilic Dendrimer as Reverse Micelle: Synthesis, Characterization and Application as Homogeneous Organocatalyst", 《TETRAHEDRON》 *
SIDDESWARAN ANAND ET AL.: "Synthesis, characterization, thermal, electrical and electrochemical studies of oligo nitrobenzimidazoles and their p-n diode applications", 《JOURNAL OF MATERIALS SCIENCE: MATERIALS IN ELECTRONICS》 *
WEI-JIE SI ET AL.: "3-Design, synthesis, antifungal activity and 3D-QSAR study of novel pyrazole carboxamide and niacinamide derivatives containing benzimidazole moiety", 《NEW JOURNAL OF CHEMISTRY》 *
WENZHI XU ET AL.: "A new fluorescent turn-on dual interaction position probe for determination of hydrazine", 《ANALYTICAL SCIENCES》 *
YANG JIAO ET AL.: "Synthesis and properties of processable poly(benzimidazole-imide)s based on 2-(3-aminophenyl)-5-aminobenzimidazole", 《JOURNAL OF POLYMER RESEARCH》 *
司伟杰: "新型苯并咪唑类化合物的设计合成及生物活性研究", 《中国优秀硕士学位论文全文数据库 工程科技I辑》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113666875A (en) * 2021-09-16 2021-11-19 湖北瑞凯兴科技股份有限公司 Method for preparing 2-phenylbenzimidazole
WO2024112287A1 (en) * 2023-08-29 2024-05-30 Banoglu Erden Benzimidazole compounds and pharmaceutical compositions and uses thereof

Similar Documents

Publication Publication Date Title
CA2656357C (en) Process for making 3-substituted 2-amino-5-halobenzamides
Farooq et al. One-pot and two-pot synthesis of chalcone based mono and bis-pyrazolines
CN111875545A (en) Directional synthesis method and application of 6-substituted benzimidazole derivative
IL165502A (en) Method for preparing 3-halo-4,5-dihydro-1h-pyrazoles
JP2002338516A (en) Method of production for 2-halogenated benzoic acids
CN106928183A (en) The preparation method of pyridyl pyrazoles alkanone carboxylic acid compound
JPS6396174A (en) Novel 5-alkylbenzoimidazole, manufacture and circulatory disease remedy
CN111943944B (en) Ethylthio-containing pyridine-bis-1, 2, 4-oxadiazole substituted benzamide compound and preparation method and application thereof
JP6732744B2 (en) Method for producing biphenylamines from azobenzols by ruthenium catalysis
JP7426481B2 (en) 3-N-cyclopropylmethyl-2-fluorobenzamide compounds, and their preparation and use
CN112250636A (en) 5-aminoimidazole compound and synthesis method thereof
CN105693632B (en) A kind of preparation method of polysubstituted quinoxaline derivant
CN106866511B (en) A kind of preparation method of polysubstituted pyridine derivative
JP2021506872A (en) Methods for the production of iminium compounds and their application in the production of pyrazole derivatives
CN106220495B (en) The method that the alpha-acyloxy ketone derivatives containing ethylenic unsaturation are directly synthesized by α-reaction kinetic of ketone
CN110606839B (en) Green synthesis method of polysubstituted quinazoline derivative
CN108299303B (en) Novel synthesis method of tetraarylpyrazole compound
CN106220554B (en) A kind of preparation method of aryl-pyridine and its derivative
CN112574070B (en) Synthesis method of substituted urea compound
CN106632194A (en) Method for preparing benzopyrone compound through adopting pentacarbonyl iron as CO release source
JP2001158773A (en) Method for producing pyridine derivative
CN108218758B (en) Preparation method of 2, 4-disubstituted pyrrole derivative
CN106336378A (en) Preparation method of quinoline-2-formic ether series
CN109438288A (en) A kind of N- nitrone substituted aroma amide derivatives and preparation method thereof
CN105175375A (en) Method for preparing benzopyrone compounds through adopting acetoxy protected alkynyl ketone

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20201103

RJ01 Rejection of invention patent application after publication